The digital version allows for searchable access on multiple devices, making it easy to pull up a high-resolution image or a specific drug dosage while on rounds.
Perhaps no area has grown faster than our understanding of the gut microbiome. The new edition provides updated insights into how microbial imbalances contribute to inflammatory bowel disease (IBD), obesity, and even systemic metabolic health. s gastrointestinal and liver disease 12th edition
In an era of "information overload," having a curated, peer-reviewed, and authoritative source is more valuable than ever. The 12th edition is edited by a team of world-renowned experts—Mark Feldman, Lawrence S. Friedman, and Lawrence J. Brandt—ensuring that every chapter reflects the highest standard of academic and clinical integrity. The digital version allows for searchable access on
With the explosion of biologics and small-molecule therapies (like JAK inhibitors), the 12th edition offers a modernized roadmap for personalized IBD treatment, focusing on "treat-to-target" strategies. In an era of "information overload," having a
The text covers the latest in therapeutic endoscopy, including third-space endoscopy (POEM), advanced imaging techniques, and the expanding role of interventional EUS. Features That Enhance Learning
The 12th edition is more than just a textbook; it is a comprehensive clinical partner. By integrating the latest genomic data, therapeutic breakthroughs, and diagnostic technologies, it ensures that practitioners are equipped to provide the best possible care for patients with digestive and liver disorders.
The field of gastroenterology moves fast, and the 12th edition has been meticulously updated to reflect the latest breakthroughs: